CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.5290
-0.0049 (-0.92%)
At close: Apr 2, 2026, 4:00 PM EDT
0.4814
-0.0476 (-9.00%)
After-hours: Apr 2, 2026, 7:52 PM EDT
CollPlant Biotechnologies Stock Forecast
CLGN's stock price has decreased by -79.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CollPlant Biotechnologies stock has a target of 11, which predicts a 1,979.40% increase from the current stock price of 0.53.
Price Target: $11 (+1,979.40%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 21, 2025.
Analyst Ratings
The average analyst rating for CollPlant Biotechnologies stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 6, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +2,168.43% | Nov 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +2,168.43% | Oct 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +2,168.43% | Sep 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +1,979.40% | Aug 21, 2025 |
Financial Forecast
Revenue This Year
8.07M
from 2.37M
Increased by 240.45%
Revenue Next Year
11.14M
from 8.07M
Increased by 38.03%
EPS This Year
-0.42
from -0.94
EPS Next Year
-0.03
from -0.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 14.5M | 20.3M |
| Avg | 8.1M | 11.1M |
| Low | 2.0M | 2.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 512.3% | 151.7% |
| Avg | 240.4% | 38.0% |
| Low | -17.3% | -69.6% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.11 | 0.18 |
| Avg | -0.42 | -0.03 |
| Low | -0.72 | -0.23 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.